3.1 Primary Health Care, Immunization Schedules & Cold Chain Integrity

Primary Health Care, Immunization Schedules & Cold Chain Integrity

Primary Health Care (PHC) forms the foundation of community nursing and universal health coverage across Jamaica and CARICOM. Formally defined in the 1978 Declaration of Alma-Ata and reaffirmed at Astana (2018), PHC recognizes health as a fundamental human right anchored by five pillars: equitable access, community participation, intersectoral collaboration, appropriate technology, and preventive orientation.

Alma-Ata Principles & The Jamaican Primary Care Network

In Jamaica, primary health care is delivered through health centres run by the four Regional Health Authorities (SERHA, NERHA, WRHA and SRHA; see Section 4.6) under parish health departments.

• Historical grading: health centres were classed Type 1 to Type 5 according to the services they offered and the population they served. Type 1 centres gave basic maternal-child and community services, often staffed by midwives and community health aides; Type 5 centres were comprehensive.
• Reform: under the primary health care reform approved by Cabinet in 2016 and carried into the Ministry of Health and Wellness strategy for 2021–2030, these are being consolidated into community, district/parish and comprehensive health centres.

Whatever the label, the team includes community health aides, public health nurses, midwives, nurse practitioners, medical officers and environmental health officers. Together they deliver child health, antenatal and postnatal care, family planning, immunisation, chronic disease clinics and home visits. Solving routine problems locally keeps hospitals for the cases that need them.

Jamaica's Expanded Programme on Immunization (EPI)

Each CARICOM country sets its own schedule. Jamaica's EPI was established in 1978. Its childhood schedule, as published in WHO's 2019 case study of Jamaica's school vaccination checks, is:

PAHO's 2024 vaccination brochure for Jamaica also lists influenza and COVID-19 vaccines for risk groups, pregnant women, health workers and older persons. Schedules change, so check the current Ministry of Health and Wellness schedule and the child's Child Health and Development Passport.

Since 1986, Jamaica's Public Health (Immunization) Regulations have required children under 7 years to be adequately immunised before admission to day care, nursery or basic school. A medically documented contraindication is the only exemption.

BCG Administration & Post-Vaccination Care

BCG is a live bacterial vaccine (Mycobacterium bovis) injected intradermally into the upper arm over the deltoid insertion, following the national protocol for the side. The dose is 0.05 mL for infants under 12 months and 0.1 mL for older children. It raises a small pale wheal. Expected progression: papule at 2–3 weeks, discharging ulceration at 5–6 weeks, and scar healing by 8–12 weeks. Teach caregivers to wash with plain water, keep dry, and never squeeze, apply ointments, or use dressings.

Vaccine Cold Chain Integrity & Storage Protocols

The cold chain maintains continuous temperature control from manufacturer to patient. Refrigerators must maintain +2°C to +8°C (+35°F to +46°F); freezers require -15°C to -25°C.

• Heat-Sensitive Vaccines: Live attenuated vaccines that degrade rapidly with heat: OPV (most fragile), Measles/MMR, BCG, and Yellow Fever. Reconstituted BCG and MMR must be refrigerated at +2°C to +8°C and discarded after 6 hours.
• Freeze-Sensitive Vaccines: Inactivated vaccines containing aluminum adjuvants. Freezing destroys adjuvants, causing loss of potency and sterile abscesses. Pentavalent, Td, Hepatitis B, PCV, HPV, and IPV must NEVER be frozen.
• Storage Rules: Place freeze-sensitive vaccines on middle shelves, spaced 2.5 cm apart, away from walls and evaporator plates. Line bottom crispers and doors with water bottles to buffer temperatures during outages. Record temperatures twice daily.

Vaccine Vial Monitors (VVM) & The WHO Shake Test

• VVM Reading: Stage 1 (inner square lighter than outer circle: usable); Stage 2 (inner square darker than stage 1 but lighter than circle: use first); Stage 3 (inner square matches circle: discard); Stage 4 (inner square darker than circle: discard).
• The WHO Shake Test: Used when a freeze-sensitive vaccine (e.g., Pentavalent) is suspected of freezing. Freeze a control vial of identical lot solid, then thaw it. Vigorously shake both suspect and thawed control vials for 15 seconds, then observe on a flat surface:
  • Freeze-Damaged: Suspect vial forms coarse granules settling rapidly within 15 minutes, clearing supernatant like the control; discard immediately.
  • Intact: Suspect vial remains uniformly turbid and settles significantly slower than the control; safe to administer.

Contraindications, AEFI Surveillance & Anaphylaxis

• True Contraindications: Severe anaphylaxis to a prior dose or constituent (e.g., yeast in HepB, neomycin in MMR); severe immunosuppression (symptomatic pediatric HIV, leukemia, systemic steroids ≥ 2 mg/kg/day for over 14 days) precludes live vaccines (BCG, MMR, OPV). In symptomatic HIV, BCG is contraindicated.
• False Contraindications: Low-grade fever (<38.5°C), mild colds, diarrhea, antimicrobial therapy, prematurity, or malnutrition do not contraindicate vaccination.
• AEFI Classification: Vaccine product-related, quality defect, immunization error-related (programmatic errors like non-sterile technique—leading cause of abscess clusters), anxiety-related (vasovagal syncope in HPV drives), and coincidental events.
• Anaphylaxis Protocol: Sudden airway obstruction (stridor, wheezing) and hypotension within 5–30 minutes post-injection require emergency action. Lay patient supine with legs elevated. Administer Intramuscular Epinephrine (Adrenaline 1:1,000 / 1 mg/mL) into the anterolateral thigh (vastus lateralis): pediatric dose 0.01 mg/kg (max 0.3 mg; adolescents 0.5 mg); adult dose 0.5 mg IM. Give oxygen, IV normal saline, repeat every 5–15 minutes as needed, and notify the Parish Health Department within 24 hours.